Genentech dissolves cancer immunology group, and research executive Ira Mellman will leave company

Genentech is dismantling its cancer immunology team in a reorganization of its work in the field, and its VP of cancer immunology, Ira Mellman, will …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

NIH Initiative on Psychedelic Therapy for Older Adults’ Chronic Pain

The TDR Three Key Takeaways regarding NIH Initiative on Psychedelic Therapy: Federal backing of psychedelic research marks a shift in policy. NIH to conduct extensive

April 30, 2024

How much more are health care’s bosses making than their employees?

How much health care’s bigwigs are making Mike Reddy for STAT Health care stocks lagged behind the broader market in 2023, and that was reflected

September 30, 2024

New Insight Into Hyperglycemia Risk With PI3K Inhibitor for Breast Cancer

Severe hyperglycemia has emerged as a common side effect among patients with PIK3CA-mutated breast cancer treated with the PI3K inhibitor alpelisib (Piqray), especially patients treated

September 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.